Society for Immunotherapy of Cancer (SITC) shared a post on LinkedIn:
“The SITC Women in Cancer Immunotherapy Network (WIN) Leadership Institute 2026 awaits you! Our program is designed to empower and elevate women in the rapidly evolving field of cancer immunotherapy.
Dive deep into insightful presentations by experienced female leaders, engage in dynamic panel discussions, and network with industry professionals. Participate in our in-person gathering July 30–31, 2026 in Boston, MA or connect virtually on Sept. 10–11, 2026. Discover how to apply effective leadership skills in real-world scenarios and navigate the unique challenges faced by female leaders in our field.
We would like to thank the dedicated SITC WIN Leadership Institute Organizers and Advisors.
Tullia Bruno, PhD – University of Pittsburgh
Lisa Butterfield, PhD – Independent Consultant
Sangeeta Goswami, MD, PhD – The University of Texas MD Anderson Cancer Center
Kristen Hege, MD – Board Member, Mersana Therapeutics, Adaptimmune, Kelonia Therapeutics, KSQ Therapeutics, Inc. and EvolveImmune Therapeutics
Sandra Demaria, MD – Weill Cornell Medicine
Teresa Foy, PhD – Bristol Myers Squibb.”
Lisa Butterfield, Distinguished Scientist at Merck, shared Society for Immunotherapy of Cancer’s post on LinkedIn, adding:
“For young women in IO looking to strengthen their leadership skillset, consider applying for the 2026 SITC Women’s Leadership Institute. We continue to refine the program and I’m really excited about what we can accomplish together this summer! Take advantage of this opportunity to further your career development.”
More posts featuring Society for Immunotherapy of Cancer and Lisa Butterfield.